Related by context. Frequent words. (Click for all words.) 73 Initiates Phase II 70 Commences Phase 69 Completes Enrollment 68 Presents Positive 68 Initiate Phase 67 Panzem R 67 Inc. NASDAQ TRGT 67 MKC# 66 Initiates Phase 66 sodium Injection 66 www.vivus.com 66 Pivotal Phase 66 Receives Orphan Drug Designation 66 GVAX R 65 www.allos.com 65 Meets Primary Endpoint 65 Pivotal Phase III 65 Inc Therapeutic Competitors 64 DWS Trust 64 refractory chronic lymphocytic 64 R sorafenib tablets 64 developing tesetaxel novel 64 BioGlue R 63 forodesine 63 inflammatory autoimmune diseases 63 Thiarabine 63 liposomal formulation 63 Clinical Trial Results 63 www.combinatorx.com 62 Inc. Nasdaq IMGN 62 www.incyte.com 62 Genasense R oblimersen 62 Phase III Clinical Trial 62 Inc. Nasdaq VVUS 62 Diamyd R 62 http:/www.nabi.com 62 developing Zerenex TM 61 Phase Ib II 61 HGS ETR2 61 Cetrorelix 61 JAK1 61 please visit http:/www.supergen.com 61 Gemzar ® 61 Pivotal Study 61 TOCOSOL Paclitaxel 61 KNS # 61 inhaled formulation 61 www.thallion.com 61 www.celgene.com 61 preclinical efficacy 61 www.delcath.com 61 Allovectin 7 R 61 Metastatic Melanoma 61 relapsed refractory multiple myeloma 61 TELINTRA 61 AMD# [002] 61 elotuzumab 60 include LibiGel ® 60 GRNVAC1 60 vosaroxin 60 www.polymedix.com 60 Pivotal Trial 60 proteasome inhibitor 60 AzaSite Plus 60 NASDAQ DYAX 60 Argatroban 60 www.wellcare.com 60 www.norsat.com 60 Recombinant Human 60 Takeda Kyowa Hakko Kirin 60 Bicifadine 60 Locteron ® 59 Daclizumab 59 phase IIb clinical 59 INCB# [001] 59 Inc. Nasdaq SUPG 59 Phase 1b clinical 59 Phase 1b trial 59 ongoing Phase 1b 59 SAR# [004] 59 Nasdaq VRTX 59 www.akorn.com 59 YOUR LOCAL ANIMAL SHELTER 59 non nucleoside polymerase 59 CYC# 59 JAK inhibitor 59 CPL Biologicals 59 anticancer compound 59 Tesetaxel 59 Paris EURONEXT SAN 59 PLK1 SNALP 59 Phase 2b clinical trials 59 Entereg R 59 Factor VIIa 59 PEG SN# 59 metastatic castration resistant 59 PEG PAL 59 www.vical.com 59 SUCCEED trial 59 Adopts Shareholder Rights 59 Diabetic Macular Edema